Back to companies

Gossamer Bio, Inc.

GOSSUSNASDAQPharmaceuticals & Healthcare

Gossamer Bio, Inc.

Revenue
$48.5mn
YoY -57.7%
Operating income
-$170.7mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API